Income Insurance and Swiss Re react to Singapore’s rising cancer costs with new insurance product

'Complete Cancer Care' has been introduced amid rising cancer treatment costs in Singapore, which is set to exceed SG$2bn (US$1.48b) by 2030.

THIS PREMIUM INSIGHT IS FOR SUBSCRIBERS ONLY.


Stay ahead with precise, independent journalism of APAC's insurance markets.

Unlocked access today:

Already subscribed? Log in here

Read next

Share this article